A detailed history of Ameritas Investment Partners, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 9,128 shares of UTHR stock, worth $3.4 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
9,128
Previous 9,434 3.24%
Holding current value
$3.4 Million
Previous $3.01 Million 8.85%
% of portfolio
0.11%
Previous 0.11%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$311.04 - $363.55 $95,178 - $111,246
-306 Reduced 3.24%
9,128 $3.27 Million
Q2 2024

Aug 13, 2024

SELL
$228.26 - $319.04 $212,053 - $296,388
-929 Reduced 8.96%
9,434 $3.01 Million
Q4 2023

Feb 14, 2024

SELL
$214.88 - $256.94 $35,025 - $41,881
-163 Reduced 1.55%
10,363 $2.28 Million
Q3 2023

Nov 13, 2023

SELL
$211.82 - $248.24 $248,464 - $291,185
-1,173 Reduced 10.03%
10,526 $2.38 Million
Q2 2023

Aug 11, 2023

BUY
$205.19 - $232.99 $19,698 - $22,367
96 Added 0.83%
11,699 $2.58 Million
Q1 2023

May 10, 2023

SELL
$212.99 - $276.17 $40,894 - $53,024
-192 Reduced 1.63%
11,603 $2.6 Million
Q4 2022

Feb 13, 2023

BUY
$205.95 - $280.43 $18,329 - $24,958
89 Added 0.76%
11,795 $3.28 Million
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $68,308 - $82,041
-336 Reduced 2.79%
11,706 $2.45 Million
Q4 2021

Feb 11, 2022

BUY
$184.32 - $216.08 $27,832 - $32,628
151 Added 1.27%
12,042 $2.6 Million
Q3 2021

Nov 15, 2021

SELL
$179.86 - $214.88 $39,029 - $46,628
-217 Reduced 1.79%
11,891 $2.2 Million
Q2 2021

Aug 06, 2021

SELL
$170.47 - $211.93 $29,661 - $36,875
-174 Reduced 1.42%
12,108 $2.17 Million
Q4 2020

Feb 12, 2021

SELL
$101.87 - $151.79 $29,644 - $44,170
-291 Reduced 2.31%
12,282 $1.86 Million
Q3 2020

Nov 13, 2020

SELL
$99.9 - $121.13 $15,884 - $19,259
-159 Reduced 1.25%
12,573 $1.27 Million
Q2 2020

Aug 05, 2020

BUY
$92.74 - $125.82 $31,346 - $42,527
338 Added 2.73%
12,732 $1.54 Million
Q3 2019

Nov 14, 2019

SELL
$74.85 - $85.99 $35,478 - $40,759
-474 Reduced 3.68%
12,394 $988,000
Q1 2018

May 15, 2018

SELL
$107.21 - $151.94 $15,974 - $22,639
-149 Reduced 1.14%
12,868 $1.45 Million
Q4 2017

Feb 14, 2018

SELL
$118.58 - $151.28 $55,495 - $70,799
-468 Reduced 3.47%
13,017 $1.93 Million
Q2 2017

Aug 15, 2017

BUY
N/A
13,485
13,485 $1.75 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.